Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CMS outlines coverage benefits for coronavirus

CMS has issued Frequently Asked Questions to provide more information on essential health benefits coverage of the new coronavirus, COVID-19, outbreak. 

Thumbnail

Most expensive drugs in the U.S.

Drug prices in the United States are higher than anywhere else in the world, and there are some prescription medicines with price tags in the millions.

Thumbnail

Survey says: U.S. hospitals have big plans for automation

Nearly two-thirds of hospitals are hoping to implement robotic process automation and AI technologies in the next two years, according to a new survey of healthcare executives.

RadNet canceling nonessential travel, implementing new center protocols in response to COVID-19

The Los Angeles-based imaging giant has also revised sick leave policies and encouraged its 8,000 employees to work from home, where possible, to limit exposure. 

Thumbnail

Patients are comfortable with AI-powered cancer screening, but still want input from physicians

Patients are on board with AI-powered skin cancer screening, according to a new study published in JAMA Dermatology. But relationships with human physicians remain a priority.

Thumbnail

Trump sends drug pricing reform principles to Congress

President Trump has sent his wish list of drug pricing reform priorities to Capitol Hill.

Thumbnail

Industry reactions to interoperability rule are a mixed bag

A set of new rules that aim to improve the interoperability of healthcare records and set a string of new requirements on healthcare providers was met with mixed reactions across the industry.

Thumbnail

CVS Health acquires 110 Midwest pharmacies

CVS Pharmacy is acquiring 110 pharmacies in the Midwest through a definitive agreement to take over Schnuck Markets' retail and specialty pharmacy businesses. An acquisition price and other financial details were not disclosed.